Dipal Doshi has been quite active with his stock holdings in Entrada Therapeutics. In recent years, he has made several significant trades, showcasing his belief in the company's potential. For instance, in early 2022, he sold shares valued at approximately...
Dipal Doshi has been quite active with his stock holdings in Entrada Therapeutics. In recent years, he has made several significant trades, showcasing his belief in the company's potential. For instance, in early 2022, he sold shares valued at approximately $1.77 million, which indicates a peak in his market confidence around that time. His trading history includes fluctuating holdings ranging from $118.85K to as high as $4.57 million by March 2024. This range highlights both his commitment to the company and responsiveness to market conditions. As of now, he has substantial shares, actively managing and trading his stock, a sign he is both invested and engaged in the company's success.